Skip to main content

Articles

Nivolumab Monotherapy as Bridge to Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma

Wayne Kuznar

Practice Management

Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy

Phoebe Starr

Multiple Myeloma, Oncology

Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma

Phoebe Starr

Cholangiocarcinoma, Oncology

Surgery for Cholangiocarcinoma

In the Literature, Oncology

Real-World Evidence Supports Patient Navigation in Cancer

Investigational BET Inhibitor, CPI-0610, Promotes Responses in Myelofibrosis

Wayne Kuznar

Corporate Culture of Health: Elusive and Expensive

David B. Nash, MD, MBA

Original Research, Practice Management

Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization

Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH

Stakeholder Perspective

Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?

Atheer A. Kaddis, PharmD

Original Research, Pulmonary

Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan

Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD

Stakeholder Perspective

Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence

F. Randy Vogenberg, PhD, FASHP

In the Literature, Oncology

Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes

Page 40 of 244
Results 391 - 400 of 2434